Phase I/IIa clinical trial in Duchenne muscular dystrophy using systematically delivered morpholino antisense oligomer to skip exon 53.

Project: Research

StatusFinished
Effective start/end date1/11/1231/10/15

Funding

European Union: £156,480

ID: 21716622